Alyssum Therapeutics Funding & Investors

Cambridge, MA

Alyssum Therapeutics, a biotechnology company which is developing next-generation immunotherapies to modulate B cells

Total Amount Raised: $26,000,000

Alyssum Therapeutics Funding Rounds

Series A
$26,000,000
Oct 22, 2024
Series A Investors
Patrick Soon-Shiong
Famy Care
Accel
Navam Capital

Funding info provided by Diffbot.